Description
Caboxen 80 mg is an oral prescription medication containing the active ingredient cabozantinib, a targeted tyrosine kinase inhibitor (TKI). Manufactured by Everest Pharmaceuticals, it functions by blocking specific enzymes that cancer cells need to grow and spread. [1, 2, 3]
Primary Uses
Caboxen is prescribed to treat several advanced cancers, including: [1]
- Metastatic medullary thyroid cancer (MTC)
- Advanced renal cell carcinoma (RCC) (kidney cancer)
- Hepatocellular carcinoma (HCC) (liver cancer) in patients previously treated with sorafenib
Reviews
There are no reviews yet.